Related Experiment Video
Updated: Feb 20, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
TGF-β signalling and PEG10 are mutually exclusive and inhibitory in chondrosarcoma cells
Naohiro Shinohara1,2, Shingo Maeda3, Yuhei Yahiro1,2
1Department of Medical Joint Materials, Kagoshima University, Kagoshima, Japan.
Abstract:
Histological distinction between enchondroma and chondrosarcoma is difficult because of a lack of definitive biomarkers. Here, we found highly active transforming growth factor-β (TGF-β) and bone morphogenetic protein (BMP) signalling in human chondrosarcomas compared with enchondromas by immunohistochemistry of phosphorylated SMAD3 and SMAD1/5. In contrast, the chondrogenic master regulator SOX9 was dramatically down-regulated in grade 1 chondrosarcoma. Paternally expressed gene 10 (PEG10) was identified by microarray analysis as a gene overexpressed in chondrosarcoma SW1353 and Hs 819.T cells compared with C28/I2 normal chondrocytes, while TGF-β1 treatment, mimicking higher grade tumour conditions, suppressed PEG10 expression. Enchondroma samples exhibited stronger expression of PEG10 compared with chondrosarcomas, suggesting a negative association of PEG10 with malignant cartilage tumours. In chondrosarcoma cell lines, application of the TGF-β signalling inhibitor, SB431542, increased the protein level of PEG10. Reporter assays revealed that PEG10 repressed TGF-β and BMP signalling, which are both SMAD pathways, whereas PEG10 knockdown increased the level of phosphorylated SMAD3 and SMAD1/5/9. Our results indicate that mutually exclusive expression of PEG10 and phosphorylated SMADs in combination with differentially expressed SOX9 is an index to distinguish between enchondroma and chondrosarcoma, while PEG10 and TGF-β signalling are mutually inhibitory in chondrosarcoma cells.
Insights
Distinguishing enchondroma from chondrosarcoma is challenging. This study identifies Paternally expressed gene 10 (PEG10) and SOX9 expression patterns, alongside transforming growth factor-β (TGF-β) and bone morphogenetic protein (BMP) signaling, as key biomarkers for differentiating these cartilage tumors.
Area of Science:
- Orthopedic oncology
- Molecular pathology
- Biomarker discovery
Background:
- Histological differentiation between enchondroma and chondrosarcoma lacks definitive biomarkers, posing diagnostic challenges.
- Transforming growth factor-β (TGF-β) and bone morphogenetic protein (BMP) signaling pathways are implicated in cartilage tumor progression.
- The role of Paternally expressed gene 10 (PEG10) in chondrosarcoma pathogenesis remains largely unexplored.
Purpose of the Study:
- To identify novel molecular markers for distinguishing enchondroma from chondrosarcoma.
- To investigate the interplay between TGF-β, BMP signaling, SOX9, and PEG10 in cartilage tumors.
- To establish a potential diagnostic index for differentiating benign and malignant cartilage lesions.
Main Methods:
- Immunohistochemistry was employed to assess phosphorylated SMAD3 and SMAD1/5 levels in enchondroma and chondrosarcoma samples.
- Microarray analysis identified differentially expressed genes, including PEG10, between chondrosarcoma and normal chondrocyte cell lines.
- In vitro experiments utilized TGF-β1 treatment, a TGF-β inhibitor (SB431542), and PEG10 knockdown in chondrosarcoma cells, coupled with reporter assays.
Main Results:
- Chondrosarcomas exhibited heightened TGF-β and BMP signaling (pSMAD3, pSMAD1/5) compared to enchondromas, while SOX9 was downregulated in grade 1 chondrosarcoma.
- PEG10 was overexpressed in chondrosarcoma cells relative to normal chondrocytes, but suppressed by TGF-β1 treatment, and showed stronger expression in enchondromas than chondrosarcomas.
- PEG10 repressed TGF-β and BMP signaling pathways, and PEG10 knockdown increased pSMAD levels, indicating a mutual inhibitory relationship.
Conclusions:
- Mutually exclusive expression of PEG10 and phosphorylated SMADs, along with differential SOX9 expression, serves as a potential index for distinguishing enchondroma from chondrosarcoma.
- PEG10 and TGF-β signaling exhibit a reciprocal inhibitory interaction within chondrosarcoma cells.
- These findings offer novel insights into the molecular mechanisms underlying cartilage tumor progression and provide potential diagnostic biomarkers.
More Related Videos
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Related Concept Videos
TGF - β Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Hedgehog Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Amplifying Signals via Enzymatic Cascade
Intracellular Signaling Affects Focal Adhesions
Some...